Login

Financial Snapshot

Revenue
TTM
$322.0M
Gross Margin
TTM
63.92%
Net Income
TTM
-$102.5M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
672.63%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$347.7M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$80.57M

Stock Price

Loading...
Market Cap: $1.5231 Billion

About Procept Biorobotics Corp

Procept BioRobotics Corp (NASDAQ: PRCT) is a surgical robotics company that develops and commercializes robotic systems for minimally invasive urological procedures. The filing excerpts provided do not contain sufficient detail to describe the revenue model, segment breakdown, customer concentration, geographic mix, competitive position, founding year, or leadership with source-period specificity. The SIC code 3841 (surgical and medical instruments) is confirmed by the 10-K filed 2026-02-26 (accession 000158897826000009). All other business details are omitted here because the supplied filing excerpts do not support them.

Source: SEC 10-K, filed 2026-02-26

Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories AtriCure Inc Conmed Corp Glaukos Corp Integer Holdings Corp NEVRO CORP NUVASIVE INC Paragon 28, Inc. Treace Medical Concepts, Inc Transmedics Group Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support